中西药联合治疗慢性前列腺炎疗效观察及不良反应分析

An analysis of adverse reactions and efficacy of integrative medicine on chronic prostatitis

目的:探讨中西联合用药治疗慢性前列腺炎的临床疗效及不良反应状况。方法:调研2016年4月-2017年3月我院普外科就诊的200例慢性前列腺炎患者,前半年收诊的100例患者视为对照组,后半年收诊的患者视为观察组。对照组慢性前列腺炎患者给予西药治疗;观察组患者在西药治疗的基础上联合中药治疗;观察两组患者经不同用药干预后的不良反应发生状况及临床疗效。结果:经不同药物干预治疗后,观察组患者显效率、总有效率等数据统计均优于对照组,P<0.05;观察组有5例患者出现不良反应,与对照组比较,P<0.05,不良反应经对症治疗后消失。经干预后,观察组的白细胞(White Blood Cell,WBC)计数及美国国立卫生研究院慢性前列腺炎临床症状积分指数(The National Institute of Health chronic prostatitis symptomindex of integral,NIH-CPSI)评分的数据统计均优于对照组,P>0.05。结论:中西联合用药干预慢性前列腺炎患者可有效提高临床疗效,增加患者治疗的依从性,减少临床不良反应的发生,值得临床医师推广。

Objective:To investigate adverse reactions and efficacy of the integrative medicine on chronic prostatitis.Methods:From April 2016 to March 2017,200 cases were divided into 2 groups,100 cases in each.The control group was given western medicine;and the observation group was given TCM medicine more.Results:After treatment,the effective rate and total efficiency in the observation group were better than the control group,P<0.05.Five patients in the observation group had adverse reactions,which were significantly different from the control group,P<0.05,and the adverse reactions disappeared after symptomatic treatment.The WBC count and NIHCPSI scores in the observation group were better,P>0.05.Conclusion:The integrative medicine on chronic prostatitis shows good effects,with less adverse reactions,and is worthy of promotion.